# InfuCare Rx®

> InfuCare Rx is a US specialty infusion provider serving people with rare, chronic, and complex conditions at home and in alternate care settings. Its model combines specialty medication dispensing, infusion nursing, reimbursement assistance, and the InfuCare Rx Health digital platform. Founded by Deven Patel in 2014, it reported more than 14,000 patients across all 50 states in November 2025.

- **Founded:** 2014
- **Headquarters:** Fairfield, United States
- **Founders:** Deven Patel (Founder and Chief Executive Officer)
- **Products:** Immunoglobulin therapy, Specialty infusion and injectables, Anti-infective therapy, Bleeding disorder services, Parenteral nutrition
- **Notable:** Expanded from a New Jersey immunoglobulin home therapy provider founded in 2014 to a nationwide specialty infusion business., Reported more than 14,000 patients across all 50 states in November 2025., Reports URAC and ACHC accreditation.

## Products & services

- **Immunoglobulin therapy** — IV and subcutaneous immunoglobulin therapy, including support for primary immunodeficiencies and neurological conditions.
- **Specialty infusion and injectables** — Specialty biologics and infusion therapies for complex inflammatory, autoimmune, and other conditions.
- **Anti-infective therapy** — Infusion services for patients prescribed anti-infective medications.
- **Bleeding disorder services** — Specialty medication and clinical support for hemophilia and other bleeding disorders.
- **Parenteral nutrition** — Intravenous nutrition services supported by a multidisciplinary clinical team.
- **InfuCare Rx Health®** — Digital care management with prescriptions, secure communication, patient management, and stakeholder reporting through online and mobile access.
- **Enrollment and reimbursement support** — Insurance verification, prior authorization documentation, financial counseling, and assistance-program guidance.
- **Home and ambulatory infusion nursing** — Patient assessment, education, administration, monitoring, and follow-up in home and alternate care settings.

## Achievements

- Expanded from a New Jersey immunoglobulin home therapy provider founded in 2014 to a nationwide specialty infusion business.
- Reported more than 14,000 patients across all 50 states in November 2025.
- Reports URAC and ACHC accreditation.
- Acquired the Florida-based Health First Infusion business assets in November 2022.
- Reported 20+ infusion nursing offices and suites in the April 2026 Tendo announcement.

## Latest updates

- **2026-09** — Participated in ASPEN Malnutrition Awareness Week, September 14-18.
- **2026-06** — Published a follow-up explaining its Tendo Marketplace participation and site-of-care coordination.
- **2026-04** — Announced a national infusion-services agreement with Tendo Marketplace.
- **2025-11** — Completed founder-led equity buyback with Guggenheim Investments as strategic capital partner; One Equity Partners exited.

## Links

- Website: https://infucarerx.com/
- LinkedIn: https://www.linkedin.com/company/infucare-rx/
- Twitter/X: https://twitter.com/infucarerx
- Instagram: https://www.instagram.com/infucarerx/
- Facebook: https://www.facebook.com/infucarerx

---

Profile page: https://yespress.io/infucare-rx
Published by YesPress — https://yespress.io
Last updated: 2026-10-21